The most comprehensive diabetes knowledge base online. Understand your diabetes. Know your supplies. Make better decisions.
MDS Diabetes
Diabetes
Encyclopedia
Shop Supplies β†’
Researchβœ“ Reviewed for accuracy

Semaglutide Cuts Heart Attack Risk But Causes Nausea

A large review of 50 trials found semaglutide reduces death and heart attack risk in high-risk patients, but significantly increases nausea, vomiting, and diarrhea.

M
MDS Diabetes Team
Β·3 min read
𝕏f
Key takeaways
  • βœ“15% lower risk of death from any cause in high-risk patients
  • βœ“23% lower risk of heart attack confirmed across 50 trials
  • βœ“Overall serious adverse events also reduced by 7%
Quick specs
JournalBMC medicine
Year2025
PMID41286875

What This Study Looked At

Researchers analyzed 50 clinical trials involving nearly 55,000 participants to understand both the benefits and side effects of semaglutide (the active ingredient in Ozempic and Wegovy) in people at higher risk of heart problems.

Who Was Studied

The participants included people with:
  • Type 2 diabetes
  • Overweight or obesity
  • Type 2 diabetes plus chronic kidney disease
  • Type 2 diabetes plus overweight

The Good News

Semaglutide showed meaningful protective effects:
  • 15% reduction in risk of death from any cause
  • 23% reduction in risk of heart attack
  • 7% reduction in serious adverse events overall
Researchers rated this evidence as high certainty, meaning we can be very confident in these findings.

The Side Effects

On the downside, semaglutide significantly increased digestive side effects:
  • Nausea: 3 times more likely compared to placebo
  • Vomiting: Over 4 times more likely
  • Diarrhea: Nearly twice as likely
Importantly, these were classified as non-serious side effects, meaning they were uncomfortable but not life-threatening.

What This Means for You

If you are at increased risk of cardiovascular events and your doctor has recommended semaglutide, this large review strongly supports its ability to protect your heart and reduce your risk of dying. The digestive side effects are real and common, but they are generally manageable and considered non-serious medically. Always discuss your individual risk-benefit balance with your healthcare team.

References & Sources

Frequently asked questions

Studies show semaglutide significantly increases the risk of nausea, vomiting, and diarrhea. These side effects are common but are considered non-serious and often improve over time as your body adjusts to the medication.
Editorial note
This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your diabetes management. Last reviewed: July 16, 2026 by the MDS Diabetes editorial team.
What to do next
πŸ“š
Read more Research articles
Explore all guides in this topic
β†’
πŸ›’
Shop related supplies at MDS
FSA/HSA eligible Β· Free shipping $60+
β†’
Topics
semaglutidecardiovascular riskheart attackside effectsGLP-1type 2 diabetesobesityresearch

Related articles

Ask Mila about diabetes